Asoy, Baby Girl .
HRN: 22-41-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
AMPICILLIN 250MG (VIAL)
12/22/2022
12/28/2022
IVT
120mg
Q12
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous SystemUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes